Hong Kong is building its own drug regulatory agency - The Hong Kong Center for Medical Products Regulation (CMPR) - under the city’s Department of Health (DoH). China is hoping this agency will be ...
Australian clinical-stage radiopharmaceutical company AdvanCell today announced the appointment of Philina Lee as chief executive (CEO) and a member of the board of directors.
US genetic medicine company Sarepta Therapeutics has announced an update to the prescribing information for Elevidys (delandistrogene moxeparvovec-rokl), its gene therapy for Duchenne muscular ...
US healthcare giant Johnson & Johnson today revealed that it has entered into a definitive agreement to acquire clinical-stage biotech Halda Therapeutics OpCo.
The past week has brought a steady flow of signals from major global regulators, offering a snapshot of how oversight is shifting as the year closes. In the United States, the Food and Drug ...
Dutch clinical-stage cancer drug developer Merus, which is developing innovative, full-length multi-specific antibodies and antibody drug conjugates (Biclonics, Triclonics and ADClonics), and ...
Canada-based clinical-stage biotech Zymeworks today announced positive top-line results from the Phase III HERIZON-GEA-01 trial evaluating Ziihera (zanidatamab-hrii) in combination with chemotherapy, ...
Established by ADQ, an active sovereign investor focused on critical infrastructure and global supply chains, Arcera is redefining what it means to build a global healthcare company from the region.
Belgium-based Agomab Therapeutics today announced positive data from 103 participants completing 12 weeks of treatment in the STENOVA Phase IIa clinical trial for ontunisertib (AGMB-129), an ...
The European Federation of Pharmaceuticals Industries and Associations (EFPIA) and Vaccine Europe (VE) are calling for clear, predictable and supportive legislation under the upcoming EU Biotech Act, ...
Sofinnova Partners, a European life sciences venture capital firm based in Paris, London and Milan, today announced the close of its latest flagship fund, Sofinnova Capital XI, at 650 million euros ...
Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a $200 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback